# Effect of Increasing Total Antioxidant Capacity in Autism Spectrum Disorder

> **NCT06623227** · NA · ENROLLING_BY_INVITATION · sponsor: **Rinvil Renaldi** · enrollment: 50 (estimated)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DIETARY_SUPPLEMENT:** Placebo
- **DIETARY_SUPPLEMENT:** Vitamin E and C

## Key facts

- **NCT ID:** NCT06623227
- **Lead sponsor:** Rinvil Renaldi
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-09-28
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-06-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-10-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06623227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06623227, "Effect of Increasing Total Antioxidant Capacity in Autism Spectrum Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06623227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*